Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)

By  

Current Cancer Drug Targets, Vol. 3, Iss. 6, 2003-12 ,pp. : 445-453

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand–receptor interaction platforms and their applications for drug discovery

By Fang Ye  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-10 ,pp. : 969-988

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 102-122

Bentham Science Publishers

Access to resources Recommend Favorite

STAT 3 as a Target for Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 834-843

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry, Metabolic Profiling and Drug Target Discovery: A Role for Metabolic Profiling in Reverse Pharmacology and Chemical Genetics

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 1, 2005-01 ,pp. : 13-20

Bentham Science Publishers

Access to resources Recommend Favorite